About Us


We at Urihk pharmaceuticals have built a strong foundation in India by launching, registering, distributing innovative drugs in the critical and neurocare segment. We also manufacture Active Pharmaceuticals Ingredient and Finished Dose Formulation of Ulinastatin in GMP certified manufacturing unit.Urihk has an experienced, dedicated, and motivated team of professionals with strong product knowledge and tremendous industry experience. Our team is passionate about healthcare, our mission is to bring world-class pharmaceutical products to the patient worldwide.

Our Services


We are a highly vertically integrated pharmaceutical company. We’ve developed a state-of-the-art facility that allows us to meet the needs of pharmaceutical companies at each stage of the business cycle. In addition to our manufacturing solutions, we also offer marketing and distribution, product registration, contract manufacturing, in-licensing and out-licensing

Marketing & distribution

Product registration

Contract Manufacturing

in-licensing and out-licensing

Flagship Products


We pride ourselves on offering innovative products at the best possible pricing, bringing the best the world has on offer to India. Targeting primarily the Critical Care and Neuro segments, we provide a variety of dosages in various forms. 

ULIHOPE

Lyophilized powder for Acute Pancreatitis and Sepsis

Ulinastatin
Strength: 100,000 IU
Primary Pack: Vial for Injection

ULICRIT Liquid

Liquid vial for for Acute Pancreatitis and Sepsis management

Ulinastatin
Strength: 100,000 IU
Primary Pack: Vial for Injection Liquid
Dr. Tarun Gupta - Co-Founder
Co-founder

Dr. Tarun Gupta

Mr. Yuan Shimin (Terry) - Co-Founder
Co-founder

Mr. Yuan Shimin (Terry)

Mr. Rajesh Sharma - Director
Director

Mr. Rajesh Sharma

Co-founder

Dr. Tarun Gupta

Professional Experience

  • Medical doctor
  • Founded Joint Force Pharmaceutical Limited in 2002
  • Established Lupin (India) Ltd.’s China operation from 1992 onwards

Co-founder

Mr. Yuan Shimin (Terry)

Professional Experience

  • Founded DrugDu (Shenzhen) Ltd. Co. in 2016
  • Founded Shenzhen Mellowhope Pharm Limited in 2001
  • One of China’s largest exporters of vaccines and biosimilar products
Director

Mr. Rajesh Sharma

Professional Experience

  • 36 years’ experience in marketing, sales and business operations at Ranbaxy and Wockhardt
  • Managed multiple businesses with sales value of $154 million and a team of 2,200 people
  • Proven track record launching new products in the Indian pharmaceutical market

Our Team


Our high caliber team brings years of global experience in pharma, whilst our on-the-ground sales force continues to adapt and expand.

Latest News


Urihk Digital

Webinar on Immunomodulators in Critical Illness held on 13 June 2021

Read more

Pathocrit - Piperacillin + Tazobactam 500 mg Logo

latest in Urihk

Urihk launches its new Antiinfective for the treatment of MDR Bacteria

Read more

AIMC

Urihk conduct of Advisory Board meeting in collaboration with Sepsis Forum of India

Read more

Gallery


Urihk is proud to host multiple events, spanning from training sessions for our staff and field force, to CMEs and international conferences for our doctors. Take a look at a few pictures that highlight our events and milestones.

Urihk Launch Event in Mumbai
Urihks Pharma Directors
Team Urihk
IESS Chennai Stage - Urihk Pharma
Dr. HN Bajaj at IESS Delhi
Dr. Yagnesh Vellore at IESS Delhi
Dr. Sajeesh Menon at IESS Chennai
Dr. P S Ramani at IESS Mumbai
Immune Dysfunction and Therapeutic Approch - Covid 19 - Presentation June 21
Immune Dysfunction and Therapeutic Approch - Sepsis, ARDS - Presentation June 21
Ulinastatin - Ulicrit Urihk Pharma - Presentation June 21
Panel Discussion - Immunomodulators in Crtical Illness Presentation 5 June 21
Cytokine Storm in covid 19 - Presentation June 21
Sepsis - Presentation June 21
Panel Discussion - Immunomodulators in Crtical Illness Presentation 6 June 21
Patient with Crtical Illness Responds Differently to Injury - Immunomodulators in Crtical Illness Presentation 7 may 21
Panel Discussion - Immunomodulators in Crtical Illness Presentation 7 may 21
Immunomodulatory Strategies in Sepsis and ARDS - Presentation May 21
Immunomodulatory Strategies in Sepsis and ARDS - Presentation May 21 Image 2
Panel Discussion - Immunomodulators in Crtical Illness Presentation 11 June 21
Immune Dysfunction and Therapeutic Approch - Covid 19 - Presentation 11 June 21
Immunomodulatory Therapies in Sepsis and ARDS - Presentation 11 June 21
Immune -Pathogenesis of ARDS Presentation 12 June 21
Immunomodulators in Crtical Illness Presentation June 21 Notes
Panel Discussion - Immunomodulators in Crtical Illness Presentation 12 June 21
Immunomodulators in Crtical Illness Presentation 12 June 21 Conclusion
Cytokine Storm in SARS COV2 - Presentation June 21
Immunomodulators in Crtical Illness Presentation 13 June 21 Conclusion
Panel Discussion - Immunomodulators in Crtical Illness Presentation 13 June 21
Uncontrolled Cytokine Release - Presentation 13 June 21